Stockreport

Ocugen to Present at the 2025 Cell & Gene Meeting on the Med

Ocugen, Inc.  (OCGN) 
PDF MALVERN, Pa., April 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness [Read more]